Unknown

Dataset Information

0

Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform-Selective Inhibitors.

ABSTRACT: A series of benzenesulfonamides incorporating pyrazole- and pyridazinecarboxamides decorated with several bulky moieties has been obtained by original procedures. The new derivatives were investigated for the inhibition of four physiologically crucial human carbonic anhydrase (hCA, EC 4.2.2.1.1) isoforms, hCA I and II (cytosolic enzymes) as well as hCA IX and XII (transmembrane, tumor-associated isoforms). Examples of isoform-selective inhibitors were obtained for all four enzymes investigated here, and a computational approach was employed for explaining the observed selectivity, which may be useful in drug design approaches for obtaining inhibitors with pharmacological applications useful as antiglaucoma, diuretic, antitumor or anti-cerebral ischemia drugs.

SUBMITTER: Angeli A 

PROVIDER: S-EPMC8625619 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform-Selective Inhibitors.

Angeli Andrea A   Kartsev Victor V   Petrou Anthi A   Pinteala Mariana M   Brovarets Volodymyr V   Vydzhak Roman R   Panchishin Svitlana S   Geronikaki Athina A   Supuran Claudiu T CT  

Molecules (Basel, Switzerland) 20211120 22

A series of benzenesulfonamides incorporating pyrazole- and pyridazinecarboxamides decorated with several bulky moieties has been obtained by original procedures. The new derivatives were investigated for the inhibition of four physiologically crucial human carbonic anhydrase (hCA, EC 4.2.2.1.1) isoforms, hCA I and II (cytosolic enzymes) as well as hCA IX and XII (transmembrane, tumor-associated isoforms). Examples of isoform-selective inhibitors were obtained for all four enzymes investigated h  ...[more]

Similar Datasets

Unknown Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors.
| S-EPMC8541628 | biostudies-literature
Unknown New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors.
| S-EPMC8398262 | biostudies-literature
Unknown Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity.
| S-EPMC9457746 | biostudies-literature
Unknown Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors.
| S-EPMC10096498 | biostudies-literature
Unknown Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
| S-EPMC6242694 | biostudies-literature
Unknown Discovery of New 1,1'-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II Inhibitors.
| S-EPMC7236029 | biostudies-literature
Unknown Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties.
| S-EPMC8150913 | biostudies-literature
Unknown Synthesis, characterization and biological evaluation of pyrazole-based benzene sulfonamides as inhibitors of human carbonic anhydrase II, IX and XII.
| S-EPMC10280043 | biostudies-literature
Unknown The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors.
| S-EPMC7178874 | biostudies-literature
Unknown Potent carbonic anhydrase I, II, IX and XII inhibition activity of novel primary benzenesulfonamides incorporating bis-ureido moieties.
| S-EPMC9987750 | biostudies-literature